Search Results

You are looking at 61 - 70 of 947 items for :

  • Refine by access: All content x
Clear All
James W Antoon Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by James W Antoon in
Google Scholar
PubMed
Close
,
William D Meacham Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by William D Meacham in
Google Scholar
PubMed
Close
,
Melyssa R Bratton Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Melyssa R Bratton in
Google Scholar
PubMed
Close
,
Evelyn M Slaughter Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Evelyn M Slaughter in
Google Scholar
PubMed
Close
,
Lyndsay V Rhodes Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Lyndsay V Rhodes in
Google Scholar
PubMed
Close
,
Hasina B Ashe Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Hasina B Ashe in
Google Scholar
PubMed
Close
,
Thomas E Wiese Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Thomas E Wiese in
Google Scholar
PubMed
Close
,
Matthew E Burow Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Matthew E Burow in
Google Scholar
PubMed
Close
, and
Barbara S Beckman Tulane Department of Pharmacology, Section of Hematology and Medical Oncology, Department of Pharmacy, Tulane Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-83, New Orleans, Louisiana 70112, USA

Search for other papers by Barbara S Beckman in
Google Scholar
PubMed
Close

Introduction Breast cancer is the second leading cause of cancer death in women today, with one in eight women diagnosed in her lifetime, and drug resistance remains the leading cause of breast cancer treatment failure. Approximately 70% of breast

Free access
Ayse Basak Engin Department of Toxicology, Faculty of Pharmacy, Gazi University, Ankara, Turkey

Search for other papers by Ayse Basak Engin in
Google Scholar
PubMed
Close
,
Atilla Engin Department of General Surgery, Faculty of Medicine, Gazi University, Ankara, Turkey

Search for other papers by Atilla Engin in
Google Scholar
PubMed
Close
, and
Ipek Isik Gonul Department of Pathology, Faculty of Medicine, Gazi University, Ankara, Turkey

Search for other papers by Ipek Isik Gonul in
Google Scholar
PubMed
Close

and intermuscular depots in obese premenopausal women ( Janiszewski et al. 2010 ). Postmenopausal patients with high visceral fat area have significantly shorter distant disease-free survival than premenopausal patients in breast cancer series

Free access
Federica Morani Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Federica Morani in
Google Scholar
PubMed
Close
,
Suratchanee Phadngam Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Suratchanee Phadngam in
Google Scholar
PubMed
Close
,
Carlo Follo Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Carlo Follo in
Google Scholar
PubMed
Close
,
Rossella Titone Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Rossella Titone in
Google Scholar
PubMed
Close
,
Gianluca Aimaretti Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Gianluca Aimaretti in
Google Scholar
PubMed
Close
,
Alessandra Galetto Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Alessandra Galetto in
Google Scholar
PubMed
Close
,
Oscar Alabiso Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Oscar Alabiso in
Google Scholar
PubMed
Close
, and
Ciro Isidoro Laboratory of Molecular Pathology and Nanobioimaging, Unit of Clinical Endocrinology, Unit of Oncology, Department of Health Sciences

Search for other papers by Ciro Isidoro in
Google Scholar
PubMed
Close

proliferating cancer cells, glucose is preferentially converted into lactate despite the presence of oxygen and functional mitochondria. This aberrant metabolism of glucose, known as the Warburg effect or aerobic glycolysis, is much less convenient in terms of

Free access
Chen-Lin Hsieh Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Chen-Lin Hsieh in
Google Scholar
PubMed
Close
,
Changmeng Cai Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Changmeng Cai in
Google Scholar
PubMed
Close
,
Ahmed Giwa Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Ahmed Giwa in
Google Scholar
PubMed
Close
,
Aaronica Bivins Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Aaronica Bivins in
Google Scholar
PubMed
Close
,
Shao-Yong Chen Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Shao-Yong Chen in
Google Scholar
PubMed
Close
,
Dina Sabry Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Dina Sabry in
Google Scholar
PubMed
Close
,
Kumara Govardhan Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Kumara Govardhan in
Google Scholar
PubMed
Close
, and
Lirim Shemshedini Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA

Search for other papers by Lirim Shemshedini in
Google Scholar
PubMed
Close

Introduction Prostate cancer is an epithelial-derived cancer ( Cussenot et al . 1994 ) that involves the action of androgens and androgen receptor (AR), a ligand-dependent transcription factor ( Chang et al . 1988 ). This liganded AR is essential

Free access
Niamh Cosgrave
Search for other papers by Niamh Cosgrave in
Google Scholar
PubMed
Close
,
Arnold D K Hill
Search for other papers by Arnold D K Hill in
Google Scholar
PubMed
Close
, and
Leonie S Young
Search for other papers by Leonie S Young in
Google Scholar
PubMed
Close

undetectable in most healthy, differentiated adult tissues but it is prominently expressed in transformed cell lines and most common human cancers ( Ambrosini et al. 1997 , Adida et al. 1998 b , Chiou et al. 2003 ). Present studies show that the

Free access
You-Hong Cheng
Search for other papers by You-Hong Cheng in
Google Scholar
PubMed
Close
,
Hiroki Utsunomiya Department of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, 303 East Superior Street, Suite 4-131, Chicago, Illinois 60611-3095, USA

Search for other papers by Hiroki Utsunomiya in
Google Scholar
PubMed
Close
,
Mary Ellen Pavone
Search for other papers by Mary Ellen Pavone in
Google Scholar
PubMed
Close
,
Ping Yin
Search for other papers by Ping Yin in
Google Scholar
PubMed
Close
, and
Serdar E Bulun
Search for other papers by Serdar E Bulun in
Google Scholar
PubMed
Close

Introduction Endometrial cancer is the most common gynecologic malignancy. It accounts for 6% of all cancers in women and is the eighth most common cause of cancer-related death in the United States ( Obel et al . 2006 ). According to the American

Free access
Caroline H Diep Hematology, Departments of Medicine, Pharmacology, Division of Physiology and Growth, Oncology, and Transplantation Division

Search for other papers by Caroline H Diep in
Google Scholar
PubMed
Close
,
Andrea R Daniel Hematology, Departments of Medicine, Pharmacology, Division of Physiology and Growth, Oncology, and Transplantation Division

Search for other papers by Andrea R Daniel in
Google Scholar
PubMed
Close
,
Laura J Mauro Hematology, Departments of Medicine, Pharmacology, Division of Physiology and Growth, Oncology, and Transplantation Division

Search for other papers by Laura J Mauro in
Google Scholar
PubMed
Close
,
Todd P Knutson Hematology, Departments of Medicine, Pharmacology, Division of Physiology and Growth, Oncology, and Transplantation Division

Search for other papers by Todd P Knutson in
Google Scholar
PubMed
Close
, and
Carol A Lange Hematology, Departments of Medicine, Pharmacology, Division of Physiology and Growth, Oncology, and Transplantation Division
Hematology, Departments of Medicine, Pharmacology, Division of Physiology and Growth, Oncology, and Transplantation Division

Search for other papers by Carol A Lange in
Google Scholar
PubMed
Close

Introduction Progesterone and progesterone receptors (PRs) are increasingly gaining attention for their emerging role as critical regulators of breast and gynecological cancers. With this newfound spotlight on PR action, there is an urgent need to

Free access
Matias Knuuttila Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, and Turku Center for Disease Modeling, University of Turku, Turku, Finland

Search for other papers by Matias Knuuttila in
Google Scholar
PubMed
Close
,
Esa Hämäläinen Department of Clinical Chemistry and HUSLAB, Helsinki University and Helsinki University Hospital, HUSLAB, Helsinki, Finland

Search for other papers by Esa Hämäläinen in
Google Scholar
PubMed
Close
, and
Matti Poutanen Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, and Turku Center for Disease Modeling, University of Turku, Turku, Finland
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Close

, supporting the hypothesis that these steroids are originating from adrenal precursors ( Turcu et al. 2016 ). Interestingly, remarkable levels of 11KT and 11KDHT were also detected in prostate tissue and plasma of prostate cancer (PCa) patients by LC

Free access
Marika H Tesselaar Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Marika H Tesselaar in
Google Scholar
PubMed
Close
,
Johannes W Smit Internal Medicine, Division of Endocrinology Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Close
,
James Nagarajah Radiology & Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by James Nagarajah in
Google Scholar
PubMed
Close
,
Romana T Netea-Maier Internal Medicine, Division of Endocrinology Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Close
, and
Theo S Plantinga Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Theo S Plantinga in
Google Scholar
PubMed
Close

Introduction Non-medullary thyroid cancer (TC) is the most frequent endocrine tumor accounting for 90% of all endocrine cancer cases. Several histological TC subtypes are distinguished as papillary TC (PTC) as the most frequent, followed by

Free access
Soojin Kim Vancouver Prostate Centre, Vancouver, British Columbia, Canada

Search for other papers by Soojin Kim in
Google Scholar
PubMed
Close
,
Daksh Thaper Vancouver Prostate Centre, Vancouver, British Columbia, Canada
Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Search for other papers by Daksh Thaper in
Google Scholar
PubMed
Close
,
Samir Bidnur Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Search for other papers by Samir Bidnur in
Google Scholar
PubMed
Close
,
Paul Toren Vancouver Prostate Centre, Vancouver, British Columbia, Canada

Search for other papers by Paul Toren in
Google Scholar
PubMed
Close
,
Shusuke Akamatsu Vancouver Prostate Centre, Vancouver, British Columbia, Canada

Search for other papers by Shusuke Akamatsu in
Google Scholar
PubMed
Close
,
Jennifer L Bishop Vancouver Prostate Centre, Vancouver, British Columbia, Canada

Search for other papers by Jennifer L Bishop in
Google Scholar
PubMed
Close
,
Colin Colins Vancouver Prostate Centre, Vancouver, British Columbia, Canada
Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Search for other papers by Colin Colins in
Google Scholar
PubMed
Close
,
Sepideh Vahid Vancouver Prostate Centre, Vancouver, British Columbia, Canada

Search for other papers by Sepideh Vahid in
Google Scholar
PubMed
Close
, and
Amina Zoubeidi Vancouver Prostate Centre, Vancouver, British Columbia, Canada
Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Search for other papers by Amina Zoubeidi in
Google Scholar
PubMed
Close

Introduction Prostate cancer (PCa) is the most commonly diagnosed and the third leading cause of cancer mortality among Canadian men ( CCSsACoC 2017 ). Initially, most cases of prostate adenocarcinoma are hormone driven and respond to androgen

Free access